Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POTASSIUM, MONOBASIC for Ill-defined disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where POTASSIUM, MONOBASIC was used for Ill-defined disorder.

Most Reported Side Effects for POTASSIUM, MONOBASIC

Side Effect Reports % Deaths Hosp.
Condition aggravated 38 25.5% 20 5
Respiratory failure 35 23.5% 20 4
Off label use 27 18.1% 0 7
Febrile neutropenia 25 16.8% 0 13
Drug hypersensitivity 21 14.1% 0 1
Toxic epidermal necrolysis 20 13.4% 0 0
Product use in unapproved indication 17 11.4% 0 0
Death 16 10.7% 16 1
Drug ineffective 14 9.4% 0 8
Macular degeneration 14 9.4% 0 8
Pyrexia 10 6.7% 2 9
Headache 9 6.0% 0 8
Abdominal pain 8 5.4% 1 7
Haematochezia 8 5.4% 1 7
Malaise 8 5.4% 0 8

Other Indications for POTASSIUM, MONOBASIC

Product used for unknown indication (75) Parenteral nutrition (31) Pneumonia (14)

Other Drugs Used for Ill-defined disorder

IBUPROFEN (707) ATORVASTATIN (570) DAPAGLIFLOZIN (556) SERTRALINE (437) AMLODIPINE (415) ROSUVASTATIN (361) OMEPRAZOLE (272) DOXYCYCLINE (254) PREGABALIN (248) LANSOPRAZOLE (227)

Related Pages

POTASSIUM, MONOBASIC Full Profile All Ill-defined disorder Drugs POTASSIUM, MONOBASIC Demographics POTASSIUM, MONOBASIC Timeline